Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
A Study to Determine Preferences Towards Interface Products
NCT03948152 · View on ClinicalTrials.gov ↗
Study Summary
Enrolled Naïve participants will be randomized to one of two arms, the investigational or control arm. Once randomized the institutions will fit the participant with the procedures outlined in the protocol. Each participant will be required to trial the mask for a period of 90 days. Any Unscheduled Visits or Calls that occur during the participants 90 days documented.
Conditions Studied
Interventions
- OTHER Standard of Care
- OTHER Mask Advice Tool
Study Locations (5)
Florida
- Pulmonary Disease Specialists, PA, d/b/a PDS Research — Kissimmee
Maryland
- Center for Sleep and Wake Disorders — Chevy Chase
Ohio
- Pullmonary Rehabilition Associates — Youngstown
Pennsylvania
- Berks Schuylkill Respiratory Specialists, Ltd. — Reading
South Carolina
- Bogan Sleep Consultants, LLC — Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 310 participants |
| Start Date | 2019-04-18 |
| Est. Completion | 2020-02-07 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03948152
The ClinicalTrials.gov registry entry for NCT03948152 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 310 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Respironics, which has 9 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Sleep Disorder; Breathing-Related appearing as the primary indexed condition, and to 2 interventions — of which Standard of Care is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT03948152 reports 5 study locations spanning 5 distinct geographic areas — top geographies include Florida, Maryland, Ohio. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT03948152 about?
NCT03948152 is a clinical study titled "A Study to Determine Preferences Towards Interface Products". Enrolled Naïve participants will be randomized to one of two arms, the investigational or control arm. Once randomized the institutions will fit the participant with the procedures outlined in the protocol. Each participant will be required to trial the mask for a period of 90 days. Any Unscheduled ...
What is the current status of trial NCT03948152?
This trial is currently completed. It is a NA study. The enrollment target is 310 participants. The study started on 2019-04-18. Estimated completion is 2020-02-07.
What conditions does trial NCT03948152 study?
This clinical trial studies the following conditions: Sleep Disorder; Breathing-Related. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT03948152?
The interventions under investigation include: Standard of Care (OTHER), Mask Advice Tool (OTHER). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT03948152?
This trial is sponsored by Philips Respironics, which has 9 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT03948152 being conducted?
This trial has 5 study locations across Florida, Maryland, Ohio, Pennsylvania, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.